7/23/2025China-Singapore Nanovaccine Prevents Cancer Recurrence in Animals

7/23/2025SAMR Orders Simcere to Reverse Unnotified Merger Over Competition, Pri...

7/23/2025DualityBio's DB‑1310 Earns FDA Fast‑Track for EGFR‑Mutated Lung Can...

7/23/2025Qilu Initiates Global Phase III Trial of QLS31905 for Pancreatic Cance...

7/23/2025Kelun‑Biotech Launches Phase I Trial of SKB107 in China to Tackle Bon...

7/22/2025CDE Solicits Comments on Proposed Labeling Update for Pediatric Use of...

7/22/2025CDE Issues Q&A Guidance on Pharmaceutical Similarity Studies for Biosi...

7/22/2025Livzon's Dual Inhibitor LZM‑012 Positive in Global Phase III Psoriasi...

7/22/2025Cloudbreak Pharma Reports Positive Phase 2 Outcomes for CBT‑004

7/22/2025Novatim Licenses Global Rights for Dual-Target CAR-T Therapy KQ-2003 t...

7/22/2025Simcere Zaiming Secures U.S. FDA Approval for IND of FGFR2b-Targeted A...

7/22/2025AusperBio Cleared to Begin Phase III Trial of AHB-137 for Chronic HepB...

7/22/2025Leads Biolabs' Hong Kong IPO Draws HK$220B in Overwhelming Demand

7/22/2025Suzhou Ribo Raises Over CNY 200M to Advance siRNA Therapeutics

7/22/2025Lannacheng Secures Over CNY 300M in Series C+ to Advance Radiopharma P...

7/22/2025Huadong Subsidiary Reports Strong Phase III Results for Roflumilast Cr...

7/22/2025Innovent Secures IND for Oral GLP‑1 Agonist IBI3032 as Mazdutide Hits...

7/22/2025Chimigen Raises ~CNY 170M to Advance Cancer and HepB Vaccines

7/21/2025Novo Nordisk, Fangzhou Partner on AI-Powered Diabetes, Obesity Care

7/18/2025Recent Executive Moves

7/18/2025SKBio Wins Chinese Clinical Trial Approval for GBP410

7/18/2025China Releases 2nd Batch of Clinical Guidelines for Rare Diseases, Cov...

7/18/2025China Seeks Comments on 96th Batch of Reference Formulations for Gener...

7/18/2025China Unveils New Clinical Trial Guidelines for Antibacterial Drugs Ta...

7/18/2025China Issues New Draft Guidelines for Pharmaceutical Development of Or...

7/18/2025Hengrui's SHR‑A1904 Emerges as Promising New Weapon Against Advanced ...

7/18/2025China Approves First Homegrown Oral Anti‑Influenza Drug by Zenshine P...

7/18/2025China Greenlights New Semaglutide Indication to Combat Kidney and Card...

7/18/2025China Approves Nation's First Recombinant Human Albumin Injection Deri...

7/18/2025Novartis CEO Highlights China Momentum in Q2 2025 Earnings Call

Page:1/54 Total number of articles:1604: [First][<<] [1] [2] [3] [4] [5] [>>] [End]